TipRanks
Innovent Biologics (DE:6IB)
FRANKFURT:6IB

Compare Innovent Biologics (6IB) vs. Competitors

4 Followers

Comparison Results

Name
Price
Market Cap
P/E Ratio
Yearly Gain
Analyst Consensus
Analyst Price Target
Compare
Top Analysts' Price Target
Smart Score
Follow
Innovent Biologics
€11.85
€19.70B
117.61
1.71%
21 Buy
0 Hold
0 Sell
Strong Buy
3SBio
HK$16.96
HK$40.64B
4.04
-47.49%
10 Buy
1 Hold
0 Sell
Strong Buy
Akeso, Inc.
HK$94.20
HK$101.88B
-89.58
-22.79%
13 Buy
0 Hold
0 Sell
Strong Buy
RemeGen Co. Ltd. Class H
HK$82.50
HK$64.01B
11.29
-42.02%
9 Buy
2 Hold
0 Sell
Strong Buy
Shanghai Junshi Biosciences Co., Ltd. Class H
HK$27.54
HK$36.73B
-83.16
-42.44%
2 Buy
1 Hold
0 Sell
Moderate Buy
Shanghai Henlius Biotech, Inc. Class H
HK$66.75
HK$32.28B
30.61
-20.06%
5 Buy
0 Hold
0 Sell
Strong Buy

Performance Comparison

Ticker
Company Name
Price
Change
% Change
DE:6IB
Innovent Biologics
11.09
0.59
5.58%
HK:1530
3SBio
15.70
-12.50
-44.33%
HK:9926
Akeso, Inc.
109.10
-22.40
-17.03%
HK:9995
RemeGen Co. Ltd. Class H
71.90
-34.30
-32.30%
HK:1877
Shanghai Junshi Biosciences Co., Ltd. Class H
17.89
-11.81
-39.76%
HK:2696
Shanghai Henlius Biotech, Inc. Class H
57.00
-18.75
-24.75%
Compare key indicators and discover each stock’s average analyst price target, as well as the latest recommendations by top Wall Street experts